Nevertheless, their tendency toward instability in the bloodstream, the complexity of their production, and the potential for inducing undesired immune responses or toxicity remain significant concerns in their clinical development [89]
Your titration journey completed: Month 1 0.25mg (initiation) Month 2 0.5mg (first therapeutic dose) Month 3+ 1mg (full maintenance dose) You are here Strength: 1mg | Form: Pre-Filled Syringe | Frequency: Once Weekly | Route: Subcutaneous injection Note: The 1mg dose is an initiation dose only
Nutritional Biochemistry
Gleneagles Healthcare Wong Chuk Hang, Hong Kong 10/F, Marina 8, 8 Heung Yip Road, Wong Chuk Hang, Hong Kong
Discovery of highly potent, selective, and orally efficacious p300/CBP histone acetyltransferases inhibitors
Once shipped, you will receive a message via email